**Author details**

Zeno Sparchez1\*, Tudor Mocan2 and Pompilia Radu2


### **References**


[17] Maccini M, Sehrt D, Pompeo A, Chicoli FA, Molina WR, Kim FJ. Biophysiologic con‐ siderations in cryoablation: aA practical mechanistic molecular review. Int Braz J Ur‐ ol. 2011;37(6):693-696.

[4] McWilliams JP, Yamamoto S, Raman SS, Loh CT, Lee EW, Liu DM, et al. Percutane‐ ous ablation of hepatocellular carcinoma: current status. J Vasc Interv Radiol.

[5] Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC. Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less.

[6] Chen MS, Li JQ, Zheng Y, Guo RP, Liang HH, Zhang YQ, et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatec‐

[7] Brunello F, Veltri A, Carucci P, Pagano E, Ciccone G, Moretto P, et al. Radiofrequen‐ cy ablation versus ethanol injection for early hepatocellular carcinoma: aA random‐

[8] Seror O. Percutaneous hepatic ablation: what needs to be known in 2014. Diagn In‐

[9] Skinner MG, Iizuka MN, Kolios MC, Sherar MD. A theoretical comparison of energy sources—microwave, ultrasound and laser—for interstitial thermal therapy. Phys

[10] Yu H, Burke CT. Comparison of percutaneous ablation technologies in the treatment

[11] Shibata T, Iimuro Y, Yamamoto Y, Maetani Y, Ametani F, Itoh K, et al. Small hepato‐ cellular carcinoma: cComparison of radio-frequency ablation and percutaneous mi‐

[12] Zhang L, Wang N, Shen Q, Cheng W, Qian GJ. Therapeutic efficacy of percutaneous radiofrequency ablation versus microwave ablation for hepatocellular carcinoma.

[13] Christophi C, Muralidharan V. Treatment of hepatocellular carcinoma by percutane‐

[14] Rapaccini GL. Percutaneous ablative treatments of hepatocellular carcinoma. Hepa‐

[15] Ferrari FS, Megliola A, Scorzelli A, Stella A, Vigni F, Drudi FM, et al. Treatment of small HCC through radiofrequency ablation and laser ablation. Comparison of tech‐

[16] Di Costanzo GG, Tortora R, D'Adamo G, De Luca M, Lampasi F, Addario L, et al. Radiofrequency ablation versus laser ablation for the treatment of small hepatocellu‐ lar carcinoma in cirrhosis: A randomized trial. J Gastroenterol Hepatol. 2015;30(3):

of malignant liver tumors. Semin Intervent Radiol. 2014;31(2):129-137.

crowave coagulation therapy. Radiology. 2002;223(2):331-337.

niques and long-term results. Radiol Med. 2007;112(3):377-393.

tomy for small hepatocellular carcinoma. Ann Surg. 2006;243(3):321-328.

ized controlled trial. Scand J Gastroenterol. 2008;43(6):727-735.

2010;21(8 Suppl):S204-213.

240 Recent Advances in Liver Diseases and Surgery

Gut. 2005;54(8):1151-1156.

terv Imaging. 2014;95(7-8):665-675.

Med Biol. 1998;43(12):3535-3547.

PLoS One. 2013;8(10):e76119.

559-565.

ous laser hyperthermia. 2001;16:548-552.

tology. 2014. doi: 10.1002/hep.27615.


[43] Huang HS, Hainfeld JF. Intravenous magnetic nanoparticle cancer hyperthermia. Int J Nanomedicine. 2013;8:2521-253.

[29] Singh R, Torti SV. Carbon nanotubes in hyperthermia therapy. Adv Drug Deliv Rev.

[30] Robinson JT, Welsher K, Tabakman SM, Sherlock SP, Wang H, Luong R, et al. High performance in vivo near-IR (>1 μm) imaging and photothermal cancer therapy with

[31] Manthe RL, Foy SP, Krishnamurthy N, Sharma B, Labhasetwar V. Tumor ablation

[32] Asharani PV, Hande MP, Valiyaveettil S. Anti-proliferative activity of silver nano‐

[33] Mironava T, Hadjiargyrou M, Simon M, Jurukovski V, Rafailovich MH. Gold nano‐ particles cellular toxicity and recovery: eEffect of size, concentration and exposure

[34] Kang B, Mackey MA, El-Sayed MA. Nuclear targeting of gold nanoparticles in cancer cells induces DNA damage, causing cytokinesis arrest and apoptosis. J Am Chem

[35] Ziyad S, Iruela-Arispe ML. Molecular mechanisms of tumor angiogenesis. Genes

[36] Danhier F, Vroman B, Lecouturier N, Crokart N, Pourcelle V, Freichels H, et al. Tar‐ geting of tumor endothelium by RGD-grafted PLGA-nanoparticles loaded with pa‐

[37] Lunov O, Syrovets T, Büchele B, Jiang X, Röcker C, Tron K, et al. The effect of carbox‐ ydextran-coated superparamagnetic iron oxide nanoparticles on c-Jun N-terminal kinase-mediated apoptosis in human macrophages. Biomaterials. 2010;31(19):

[38] Kobayashi T. Biotechnol J. Cancer hyperthermia using magnetic nanoparticles.

[39] Tartaj P, Puerto Morales P, Veintemillas-Verdaguer S, Carre T, Carlos J Serna J. The preparation of magnetic nanoparticles for applications in biomedicine Phys. D: Appl.

[40] Batlle X, Labarta A. Finite-size effects in fine particles: mMagnetic and transport

[41] Johannsen M, Gneveckow U, Thiesen B, Taymoorian K, Cho CH, Waldöfner N, et al. Thermotherapy of prostate cancer using magnetic nanoparticles: fFeasibility, imag‐ ing, and three dimensional temperature distribution. Eur Urol 2007;52(6):1653-1661.

[42] Rosensweig RE. Heating magnetic fluid with alternating magnetic field. J Magn

2013;65(15):2045-20460.

242 Recent Advances in Liver Diseases and Surgery

carbon nanotubes. Nano Res. 2010;3(11):779-793.

particles. BMC Cell Biol. 2009;10:65.

Soc. 2010;132(5):1517-1519.

Cancer. 2011;2(12):1085-1096.

5063-50671.

2011;6(11):1342-1347.

Phys. 2003;36:182-197

time. Nanotoxicology. 2010;4(1):120-137.

clitaxel. J Control Release. 2009;140(2):166-173.

properties J. Phys. D: Apply. Phys. 2002;35:R15.

Magn Mater. 2002;252(1-3):370-374.

and nanotechnology. Mol Pharm. 2010;7(6):1880-1898.


[68] Phillips WT, Bao A, Brenner AJ, Goins BA. Image-guided interventional therapy for cancer with radiotherapeutic nanoparticles. Adv Drug Deliv Rev. 2014, 30;76: 39-59.

[56] Johannsen M, Thiesen B, Gneveckow U, Taymoorian K, Waldöfner N, Scholz R, et al. Thermotherapy using magnetic nanoparticles combined with external radiation in an

[57] Shinkai M, Yanase M, Honda H, Wakabayashi T, Yoshida J, Kobayashi T. Intracellu‐ lar hyperthermia for cancer using magnetite cationic liposome–in vitro study. Jpn. J.

[58] Ito A, Tanaka K, Honda H, Abe S et al., Complete regression of mouse mammary carcinoma with a size greater than 15 mm by frequent repeated hyperthermia using

[59] Zhang J, Misra RD. Magnetic drug-targeting carrier encapsulated with thermosensi‐ tive smart polymer: core-shell nanoparticle carrier and drug release response. Acta

[60] Hu SH, Liao BJ, Chiang CS, Chen PJ, Chen IW, Chen SY. Core-shell nanocapsules sta‐ bilized by single-component polymer and nanoparticles for magneto-chemotherapy/

[61] Johannsen M, Gneveckow U, Taymoorian K, Cho CH, Thiesen B, Scholz R, et al. Thermal therapy of prostate cancer using magnetic nanoparticles. Actas Urol Esp.

[62] Maier-Hauff K, Rothe R, Scholz R, Gneveckow U, Wust P, Thiesen B, et al. Intracrani‐ al thermotherapy using magnetic nanoparticles combined with external beam radio‐ therapy: rResults of a feasibility study on patients with glioblastoma multiforme. J

[63] van Landeghem FK, Maier-Hauff K, Jordan A, Hoffmann KT, Gneveckow U, Scholz R, et al. Post-mortem studies in glioblastoma patients treated with thermotherapy us‐

[64] Takamatsu S, Matsui O, Gabata T, Kobayashi S, Okuda M, Ougi T, et al. Selective in‐ duction hyperthermia following transcatheter arterial embolization with a mixture of nano-sized magnetic particles (ferucarbotran) and embolic materials: Feasibility

[65] Yuan Y, Wyatt C, Maccarini P, et al. A heterogeneous human tissue mimicking phan‐ tom for RF heating and MRI thermal monitoring verification. Phys Med Biol.

[66] Wiekhorst F, Steinhoff U, Eberbeck D, Trahms L. Magnetorelaxometry assisting bio‐ medical applications of magnetic nanoparticles. Pharm Res. 2012;29(5):1189-1202.

[67] Widmann G, Schullian P, Haidu M, Bale R. Stereotactic radiofrequency ablation (SRFA) of liver lesions: tTechnique effectiveness, safety, and interoperator perform‐

hyperthermia with multiple drugs. Adv Mater. 2012;24(27):3627-3632.

orthotopic rat model of prostate cancer. Prostate. 2006;66:97-104.

magnetite nanoparticles. J. Biosci. Bioeng. 2003;96:364-369.

ing magnetic nanoparticles. Biomaterials. 2009;30(1):52-57.

study in rabbits. Radiat Med. 2008;26:179-187.

ance. Cardiovasc Intervent Radiol. 2012;35(3):570-580.

Cancer Res. 1996:87;1179.-183.

244 Recent Advances in Liver Diseases and Surgery

Biomater. 2007;3(6):838-850.

Neurooncol. 2007;81(1):53-60.

2007;31(6):660-667.

2012;57(7):2021-2037.


[94] Clement GT. Perspectives in clinical uses of high-intensity focused ultrasound. Ultra‐ sonics. 2004;42:1087-1093.

[81] Needham D, Anyarambhatla G, Kong G, Dewhirst MW. A new temperature sensi‐ tive liposome for use with mild hyperthermia: cCharacterization and testing in a hu‐

[82] Unezaki S, Maruyama K, Takahashi N, Koyama M, Yuda T, Suginaka A, Iwatsuru M. Enhanced delivery and antitumor activity of doxorubicin using long-circulating ther‐ mosensitive liposomes containing amphipathic polyethylene glycol in combination

[83] Lindner LH, Eichhorn ME, Eibl H, Teichert N, Schmitt-Sody M, Issels RD, Dellian M. Novel temperature-sensitive liposomes with prolonged circulation time. Clin Cancer

[84] Li T, Zhang M, Han Y, Zhang H, Xu L, Xiang Y. Targeting therapy of choroidal neo‐ vascularization by use of polypeptide- and PEDF-loaded immunoliposomes under ultrasound exposure. J Huazhong Univ Sci Technolog Med Sci. 2010;30(6):798-803.

[85] Seynhaeve AL, Hoving S, Schipper D, Vermeulen CE, de Wiel-AmbagtsheerGa, van Tiel ST, et al. Tumor necrosis factor alpha mediates homogeneous distribution of lip‐ osomes in murine melanoma that contributes to a better tumor response. Cancer Res.

[86] Harrington KJ, Mohammadtaghi S, Uster PS, Glass D, Peters AM, Vile RG, Stewart JS. Effective targeting of solid tumors in patients with locally advanced cancers by ra‐

[87] Ta T, Porter TM. Thermosensitive liposomes for localized delivery and triggered re‐

[88] Allen TM, Cullis PR. Liposomal drug delivery systems: From concept to clinical ap‐

[89] Horsman MR, Overgaard J. Can mild hyperthermia improve tumour oxygenation?

[90] Karino T, Koga S, Maeta M. Experimental studies of the effects of local hyperthermia on blood flow, oxygen pressure and pH in tumors. Jpn J Surg. 1988;18(3):276-283.

[91] Fujiwara K, Watanabe T. Effects of hyperthermia, radiotherapy and thermoradiother‐ apy on tumor microvascular permeability. ActaPathol Jpn. 1990;40(2):79-84.

[92] Li L, ten Hagen TL, Bolkestein M, Gasselhuber A, Yatvin J, van Rhoon GC, Egger‐ mont AM, Haemmerich D, Koning GA. Improved intratumoral nanoparticle extrava‐ sation and penetration by mild hyperthermia. J ControlRelease. 2013;28 167(2):

[93] Kennedy JE. High-intensity focused ultrasound in the treatment of solid tumours.

diolabeled pegylated liposomes. Clin Cancer Res. 2001;7(2):243-254.

lease of chemotherapy. J ControlRelease. 2013;10 169(1-2):112-125.

plications. Adv Drug Deliv Rev. 2013;65:36-48.

Int J Hyperthermia. 1997;13(2):141-147.

Nat Rev Cancer. 2005;5:321-392.

man tumor xenograft model. Cancer Res. 2000;60(5):1197-1201.

with local hyperthermia. Pharm Res. 1994;11(8):1180-1185.

Res. 2004;10(6):2168-2178.

246 Recent Advances in Liver Diseases and Surgery

2007;67(19):9455-9462.

130-137.

